Gordon Keller, Princess Margaret Cancer Centre, University Health Network, USA

Gordon Keller

Gordon Keller earned his PhD in Immunology at the University of Alberta and completed a Post Doctoral Fellowship at the Ontario Cancer Institute in 1983. His career has taken him to Basel, Austria, Denver and New York. In 2007, Keller returned to Canada to accept the position of Director, McEwen Centre for Regenerative Medicine in Toronto. Dr. Keller is best known for his research in lineage specific differentiation of mouse and human embryonic stem cells. In December 2016, Keller was named scientific co-founder of BlueRock Therapeutics, a next-generation regenerative medicine company.

« Go Back

Supporting Publication